Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O43813
UPID:
LANC1_HUMAN
Alternative names:
40 kDa erythrocyte membrane protein; LanC-like protein 1
Alternative UPACC:
O43813
Background:
Glutathione S-transferase LANCL1, also known as the 40 kDa erythrocyte membrane protein or LanC-like protein 1, plays a crucial role in cellular defense mechanisms. It functions by catalyzing the conjugation of glutathione (GSH) to various substrates, including 1-chloro-2,4-dinitrobenzene and p-nitrophenyl acetate. This process is vital for mitigating neuronal oxidative stress, supporting normal postnatal development, and responding to oxidative challenges through the GSH antioxidant defense mechanism. Additionally, LANCL1 may influence EPS8 signaling and has a known affinity for binding glutathione.
Therapeutic significance:
Understanding the role of Glutathione S-transferase LANCL1 could open doors to potential therapeutic strategies. Its involvement in antioxidant defense and stress response mechanisms highlights its potential as a target for developing treatments aimed at neurological conditions characterized by oxidative stress.